JP2013504610A5 - - Google Patents

Download PDF

Info

Publication number
JP2013504610A5
JP2013504610A5 JP2012529270A JP2012529270A JP2013504610A5 JP 2013504610 A5 JP2013504610 A5 JP 2013504610A5 JP 2012529270 A JP2012529270 A JP 2012529270A JP 2012529270 A JP2012529270 A JP 2012529270A JP 2013504610 A5 JP2013504610 A5 JP 2013504610A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
aqueous liquid
liquid pharmaceutical
surfactant
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012529270A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504610A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/063610 external-priority patent/WO2011033019A1/en
Publication of JP2013504610A publication Critical patent/JP2013504610A/ja
Publication of JP2013504610A5 publication Critical patent/JP2013504610A5/ja
Withdrawn legal-status Critical Current

Links

JP2012529270A 2009-09-16 2010-09-16 インスリンを含む安定な非水性液体医薬組成物 Withdrawn JP2013504610A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170389 2009-09-16
EP09170389.2 2009-09-16
PCT/EP2010/063610 WO2011033019A1 (en) 2009-09-16 2010-09-16 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin

Publications (2)

Publication Number Publication Date
JP2013504610A JP2013504610A (ja) 2013-02-07
JP2013504610A5 true JP2013504610A5 (cg-RX-API-DMAC7.html) 2013-10-31

Family

ID=41622804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529270A Withdrawn JP2013504610A (ja) 2009-09-16 2010-09-16 インスリンを含む安定な非水性液体医薬組成物

Country Status (5)

Country Link
US (2) US20120196800A1 (cg-RX-API-DMAC7.html)
EP (1) EP2477644A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013504610A (cg-RX-API-DMAC7.html)
CN (1) CN102481343A (cg-RX-API-DMAC7.html)
WO (1) WO2011033019A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
BR112012016853A2 (pt) * 2010-01-12 2017-10-17 Novo Nordisk As "composições farmacêuticas para administração oral de peptídeos de insulina".
EP2836508B1 (en) 2012-04-11 2016-06-29 Novo Nordisk A/S Insulin formulations
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
CN114796479B (zh) * 2022-06-02 2026-02-10 金宇保灵生物药品有限公司 一种畜类动物疫苗用水包油包水佐剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004893A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
CN1160122C (zh) * 2001-04-20 2004-08-04 清华大学 一种制备口服胰岛素油相制剂的方法
AU2003272347A1 (en) * 2002-09-17 2004-04-08 Merck And Co., Inc. Removal of aldehyde impurity by reactive polystyrene resin
ES2435522T3 (es) * 2005-02-02 2013-12-20 Novo Nordisk A/S Derivados de insulina
CN101180081B (zh) 2005-05-25 2015-08-26 诺沃-诺迪斯克有限公司 稳定的多肽制剂
CN101541830A (zh) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
AU2008257505B2 (en) * 2007-06-01 2013-05-16 Novo Nordisk A/S Stable non-aqueous pharmaceutical compositions
EP2514406A1 (en) * 2007-06-01 2012-10-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues

Similar Documents

Publication Publication Date Title
RU2015108930A (ru) Фармацевтическая композиция, содержащая луликоназол
RU2009104140A (ru) Композиции для ухода за полостью рта, содержащие гелевые сетки
AR038901A1 (es) Metodos extractivos para purificar sucralosa
CA2517493A1 (en) Therapeutic patch with polysiloxane matrix comprising capsaicin
JP2011190451A5 (cg-RX-API-DMAC7.html)
WO2001051598A1 (en) Process for making an enriched mixture of polyunsaturated fatty acid esters
WO2012071389A3 (en) Stable cannabinoid compositions and methods for making and storing them
JP2012510438A5 (cg-RX-API-DMAC7.html)
MY173044A (en) Recovery of phytonutriens from oils
RU2017127531A (ru) Фармацевтические составы, включающие кангрелор высокой чистоты, и способы их получения и применения
JP6521274B2 (ja) タキサンを含む経口投与用薬学的組成物
NZ601001A (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
JP6129584B2 (ja) 加熱調理用油脂組成物及び該加熱調理用油脂組成物の製造方法
JP2019535668A (ja) 注射デバイスのための医薬ヒドロコルチゾン溶液
CN105566167B (zh) 一种脲包工艺中尿素的回收方法
CN102295989A (zh) 一种除去动植物油脂中邻苯二甲酸酯类物质的方法
KR102140251B1 (ko) 초임계수 처리 사과세포배양추출물을 포함하는 액정수화 화장료 조성물
JPH11503066A (ja) ヒドロフルオロカーボンを含む組成物及び固体表面から水を除去する方法
JP2010516761A5 (cg-RX-API-DMAC7.html)
AR075144A1 (es) Procedimiento para obtener una fraccion enriquecida en esteres de acidos grasos funcionalizados, a partir de semillas de plantas oleaginosas
RU2018109859A (ru) Способ комбинированного разрушения клеток и экстракции маслосодержащих семян
KR101612257B1 (ko) 고농도의 탁산을 포함하는 경구 투여용 약학 조성물
AU2006313172B2 (en) Method of refining episesamin
ES2195990T3 (es) Proceso para la preparacion de poli (alcohol vinilico).
JP2014533694A5 (cg-RX-API-DMAC7.html)